| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Ketoconazole 20 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Miconazole nitrate 20 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Sulconazole nitrate 10 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely undecylenic acid 50 milligram/1 gram and zinc undecylenate 200 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Amorolfine (as amorolfine hydrochloride) 2.5 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely aciclovir 50 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Penciclovir 10 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Povidone iodine 50 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely benzalkonium chloride 100 microgram/1 gram and cetrimide 2 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Dibrompropamidine isetionate 1.5 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Polynoxylin 100 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely cetrimide 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely hydrogen peroxide 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely hydrogen peroxide 15 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Heparinoid 3 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Hydroquinone 20 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Azelaic acid 200 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Hydrocortisone 5 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Permethrin stain 50 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely cinchocaine 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| betametasondipropionat 0,5 mg/g, kräm |
Has manufactured dose form |
False |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone probutate 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Desonide 500 microgram/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely diflorasone diacetate 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Fludroxycortide 250 microgram/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely fludroxycortide 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Triamcinolone acetonide 250 microgram/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely triamcinolone acetonide 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| hydrokortisonacetat 2,5 % kräm |
Has manufactured dose form |
False |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely fluorouracil 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely urea 400 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely lidocaine hydrochloride 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Amphotericin B 30 mg/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely desoximetasone 2.5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Desoximetasone 500 microgram/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Amcinonide 1 mg/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely tretinoin 200 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely fluorouracil 5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone valerate 2 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Betamethasone (as betamethasone dipropionate) 500 microgram/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| betametasondipropionat 0,5 mg, kräm |
Has manufactured dose form |
False |
Cutaneous cream |
Inferred relationship |
Some |
|
| Triamcinolone acetonide 1 mg/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Tretinoin 1 mg/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely hydroquinone 40 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Fluocinolone acetonide 250 microgram/g and neomycin sulfate 5 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 160 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone acetate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Fluocinolone acetonide 100 microgram/mL and hydroquinone 40 mg/mL and tretinoin 500 microgram/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Fluprednidene acetate 1 mg/g and miconazole nitrate 20 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely fluocinonide 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Lidocaine 70 mg/g and tetracaine 70 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely imiquimod 37.5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| antralin 0,2 %, hudkräm |
Has manufactured dose form |
False |
Cutaneous cream |
Inferred relationship |
Some |
|
| antralin 0,4 %, hudkräm |
Has manufactured dose form |
False |
Cutaneous cream |
Inferred relationship |
Some |
|
| Benzoyl peroxide 100 mg/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| bensoylperoxid 8 %, hudkräm |
Has manufactured dose form |
False |
Cutaneous cream |
Inferred relationship |
Some |
|
| Diflucortolone valerate 3 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely butenafine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Chlorhexidine gluconate 10 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Clobetasol propionate 500 microgram/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely desoximetasone 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely haloprogin 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Halobetasol propionate 500 microgram/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely hydroquinone 40 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| lanolin 4 % + zinkoxid 8 %, hudkräm |
Has manufactured dose form |
False |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely imiquimod 50 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Diiodohydroxyquinoline 10 mg/mL and hydrocortisone 10 mg/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| mafenidacetat 85 mg/g, hudkräm |
Has manufactured dose form |
False |
Cutaneous cream |
Inferred relationship |
Some |
|
| Tazarotene 500 microgram/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely tazarotene 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely fluocortolone hexanoate 2.5 milligram/1 gram and fluocortolone pivalate 2.5 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| betametasondipropionat 640 mikrogram/gram och klotrimazol 10 milligram/gram, hudkräm |
Has manufactured dose form |
False |
Cutaneous cream |
Inferred relationship |
Some |
|
| eflornitin (som eflornitinhydrokloridmonohydrat) 115 milligram/gram, hudkräm |
Has manufactured dose form |
False |
Cutaneous cream |
Inferred relationship |
Some |
|
| Hydrocortisone acetate 10 mg/mL and pramocaine hydrochloride 10 mg/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone acetate 25 milligram/1 milliliter and pramocaine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Eflornithine (as eflornithine hydrochloride) 139 mg/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| metylaminolevulinathydroklorid 168 milligram/milliliter, hudkräm |
Has manufactured dose form |
False |
Cutaneous cream |
Inferred relationship |
Some |
|
| Mupirocin (as mupirocin calcium) 20 mg/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Betamethasone valerate 1 mg/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely mafenide (as mafenide acetate) 85 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Gentamicin (as gentamicin sulfate) 1 mg/mL cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely gentamicin (as gentamicin sulfate) 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Silver sulfadiazine 10 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Clascoterone 10 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Eflornithine (as eflornithine hydrochloride) 115 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 gram and clotrimazole 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely clotrimazole 10 milligram/1 gram and hydrocortisone (as hydrocortisone acetate) 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Methyl aminolevulinate (as methyl aminolevulinate hydrochloride) 168 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely halometasone 500 microgram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Product containing precisely pimecrolimus 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Coal tar 60 mg/g and salicylic acid 30 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|
| Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream |
Has manufactured dose form |
True |
Cutaneous cream |
Inferred relationship |
Some |
|